title: Cardiovascular pharmacogenomics and individualized drug therapy.
abstract: The goal of individualized drug therapy requires physicians to be able to accurately predict an individual's response to a drug. Both genetic and environmental factors are known to influence drug response. 'Pharmacogenetics' is the study of the role of inheritance in variation in drug response phenotypes. Pharmacogenetics is now moving genome-wide to become 'pharmacogenomics', resulting in the recognition of novel biomarkers for individual variation in drug response. This article reviews the development, promise and challenges facing pharmacogenomics, using examples of drugs used to treat or prevent cardiovascular disease.
authors.affiliation: Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA. pereira.naveen@mayo.edu
authors.forename: Naveen L
authors.initials: NL
authors.lastname: Pereira
authors.forename: Richard M
authors.initials: RM
authors.lastname: Weinshilboum
mesh_terms: D002317:Cardiovascular Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000235:genetics; D005820:Genetic Testing; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D018579:Patient Selection; D010375:Pedigree; D010597:Pharmacogenetics / Q000639:trends; D010641:Phenotype; D057285:Precision Medicine / Q000639:trends
chemical_list: D002317:Cardiovascular Agents
references.citation: Mol Cancer Ther. 2006 Nov;5(11):2601-5
references.pmid: 17088435
references.citation: N Engl J Med. 2002 Oct 10;347(15):1135-42
references.pmid: 12374873
references.citation: N Engl J Med. 2008 Aug 21;359(8):789-99
references.pmid: 18650507
references.citation: Lancet. 1999 Feb 27;353(9154):717-9
references.pmid: 10073515
references.citation: JAMA. 2004 Jul 21;292(3):344-50
references.pmid: 15265849
references.citation: Ann Intern Med. 2009 Jan 20;150(2):73-83
references.pmid: 19153410
references.citation: N Engl J Med. 2009 Feb 19;360(8):753-64
references.pmid: 19228618
references.citation: Ann Intern Med. 2007 Dec 4;147(11):755-65
references.pmid: 18056659
references.citation: N Engl J Med. 1964 Oct 15;271:809-15
references.pmid: 14187664
references.citation: Hum Mutat. 1999 Sep 19;14(3):271
references.pmid: 10477438
references.citation: J Am Med Assoc. 1957 Oct 19;165(7):835-7
references.pmid: 13462859
references.citation: Pharmacogenomics J. 2007 Feb;7(1):29-37
references.pmid: 16636683
references.citation: J Biol Chem. 2000 Jul 28;275(30):23059-64
references.pmid: 10801795
references.citation: Pharmacol Res. 2007 Apr;55(4):310-7
references.pmid: 17289397
references.citation: Cancer Res. 2008 Sep 1;68(17):7050-8
references.pmid: 18757419
references.citation: JAMA. 2008 Mar 19;299(11):1335-44
references.pmid: 18349094
references.citation: Ann Hum Genet. 1959 Jul;23:239-50
references.pmid: 14404182
references.citation: Hum Mol Genet. 2008 Oct 15;17(R2):R174-9
references.pmid: 18852207
references.citation: N Engl J Med. 2008 Jun 19;358(25):2661-3
references.pmid: 18565857
references.citation: Clin Pharmacol Ther. 1975 Jun;17(6):722-30
references.pmid: 237647
references.citation: Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11825-9
references.pmid: 7903454
references.citation: Nat Med. 2008 May;14(5):510-7
references.pmid: 18425130
references.citation: Pharmacogenetics. 2003 May;13(5):247-52
references.pmid: 12724615
references.citation: N Engl J Med. 2009 Jan 22;360(4):354-62
references.pmid: 19106084
references.citation: J Pharmacol Exp Ther. 1996 Jul;278(1):441-6
references.pmid: 8764380
references.citation: Clin Pharmacol Ther. 2008 Sep;84(3):301-3
references.pmid: 18714317
references.citation: N Engl J Med. 1982 Dec 16;307(25):1558-60
references.pmid: 7144837
references.citation: N Engl J Med. 2005 Jan 20;352(3):225-37
references.pmid: 15659722
references.citation: N Engl J Med. 2005 Jun 2;352(22):2285-93
references.pmid: 15930419
references.citation: Nature. 2004 Feb 5;427(6974):537-41
references.pmid: 14765194
references.citation: Science. 1968 Jul 5;161(3836):72-3
references.pmid: 5690279
references.citation: Genomics. 1988 Feb;2(2):174-9
references.pmid: 3410476
references.citation: N Engl J Med. 2008 Mar 6;358(10):999-1008
references.pmid: 18322281
references.citation: J Pharmacol Exp Ther. 1957 Jun;120(2):203-14
references.pmid: 13463742
references.citation: N Engl J Med. 2001 May 31;344(22):1659-67
references.pmid: 11386264
references.citation: Am J Hum Genet. 1989 Dec;45(6):889-904
references.pmid: 2574001
references.citation: Pharmacoeconomics. 2007;25(11):899-902
references.pmid: 17960949
references.citation: Curr Opin Lipidol. 2007 Aug;18(4):409-14
references.pmid: 17620857
references.citation: Eur J Clin Pharmacol. 1979 Sep;16(3):183-7
references.pmid: 499318
references.citation: Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11288-93
references.pmid: 16844790
references.citation: J Lab Clin Med. 1970 Jul;76(1):114-25
references.pmid: 4912962